← Leaderboards
Tracey Jane Lamb
Emory University
$8,710,457
Attributed
$11,141,531
Total exposure
9
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.3M · FY2013–25$2.5M$1.9M$1.3M$625K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$11,141,531 · 9
By mechanism
R01$6,929,735 · 3
DP2$2,295,416 · 1
R21$1,503,598 · 4
T32$412,782 · 1
Top collaborators
- Brian D. Evavold6 shared
- Samuel H Speck2 shared
- Matthew A Williams2 shared
Most similar at Emory University
Same institution · by research overlap
- Mary R Galinski$18,988,233
- Christian P Larsen$35,318,088
- Jay Michael Weiss$7,154,712
- Leslie S Kean$43,609,566
- Alberto Moreno$7,414,543
Others in their field
Top investigators on “Infection”
- Wafaa M. El-Sadr · Columbia University Health Sciences$965,939,185
- Lawrence Corey · Fred Hutchinson Cancer Center$789,608,171
- Judith S. Currier · University Of California Los Angeles$511,038,212
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$463,711,983
- Richard Marlink · Elizabeth Glaser Pediatric Aids Fdn$457,210,249
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$415,229,497
Research focus
InfectionDisabilityMalariaMissionHuman DiseaseMediatingResponseEventPlasmodiumUnited States National Institutes Of HealthCerebral MalariaImmune ResponseCessation Of LifePublic HealthPathogenesisInsightChildCellsParasitesT-LymphocytePlasmodium BergheiBloodDesignAdhesions
Grant awards (26)
Pathogenic low affinity CD8 T cells in malaria$615,928
R01 · FY2025 · AI · contact PI
Innate iNKT Cells Shape Organ-Specific Pathogenesis in Plasmodium Infection$423,500
R21 · FY2025 · AI · contact PI
Cross-disciplinary Training in Immunology, Inflammation and Infectious Disease$243,385
T32 · FY2025 · AI · contact PI
Elucidating influenza-induced protection of malaria-associated respiratory distress syndrome in mice$224,070
R21 · FY2025 · AI · contact PI
Pathogenic low affinity CD8 T cells in malaria$628,128
R01 · FY2024 · AI · contact PI
Cross-disciplinary Training in Immunology, Inflammation and Infectious Disease$169,397
T32 · FY2024 · AI · contact PI
Pathogenic low affinity CD8 T cells in malaria$713,073
R01 · FY2023 · AI · contact PI
Pathogenic low affinity CD8 T cells in malaria$653,615
R01 · FY2022 · AI · contact PI
Genetic and Immunological Control for Development of Asymptomatic Malaria$190,625
R21 · FY2022 · AI · contact PI
Pathogenic low affinity CD8 T cells in malaria$653,615
R01 · FY2021 · AI · contact PI
Suppression of anti-malarial humoral immune responses by gamaherpesviruses$383,290
R01 · FY2021 · AI · contact PI
EphA2 mediates opening of the blood brain barrier in cerebral malaria$356,155
R01 · FY2021 · NS · contact PI
Genetic and Immunological Control for Development of Asymptomatic Malaria$228,750
R21 · FY2021 · AI · contact PI
Suppression of anti-malarial humoral immune responses by gamaherpesviruses$383,241
R01 · FY2020 · AI · contact PI
EphA2 mediates opening of the blood brain barrier in cerebral malaria$363,811
R01 · FY2020 · NS · contact PI
EphA2 mediates opening of the blood brain barrier in cerebral malaria$390,388
R01 · FY2019 · NS · contact PI
Suppression of anti-malarial humoral immune responses by gamaherpesviruses$378,899
R01 · FY2019 · AI · contact PI
Suppression of anti-malarial humoral immune responses by gamaherpesviruses$366,454
R01 · FY2018 · AI · contact PI
EphA2 mediates opening of the blood brain barrier in cerebral malaria$281,346
R01 · FY2018 · NS · contact PI
EphA2 mediates opening of the blood brain barrier in cerebral malaria$69,455
R01 · FY2018 · NS · contact PI
Suppression of anti-malarial humoral immune responses by gamaherpesviruses$395,053
R01 · FY2017 · AI · contact PI
EphA2 mediates opening of the blood brain barrier in cerebral malaria$297,284
R01 · FY2017 · NS · contact PI
Ephrin ligands as novel targets for an adjunct therapy in cerebral malaria$195,000
R21 · FY2015 · NS · contact PI
Ephrin ligands as novel targets for an adjunct therapy in cerebral malaria$241,653
R21 · FY2014 · NS · contact PI
The development of probiotic yeast as an inexpensive vaccine delivery platform$1,994,217
DP2 · FY2013 · AI · contact PI
The development of probiotic yeast as an inexpensive vaccine delivery platform$301,199
DP2 · FY2013 · AI · contact PI